2026 Pilot Research Grants support collaborative research teams studying metabolic dysfunction and vascular disease to advance scientific understanding, patient-centered care, and patient outcomes.
Funder: Foundation to Advance Vascular Cures
Due Dates (Anticipated): August 2027 (Application deadline)
Funding Amounts: Up to $75,000 per project for up to 15 months; up to two projects funded
Summary: Supports collaborative pilot research connecting metabolic dysfunction and vascular disease to improve science, care, and patient outcomes.
Key Information: Proposals must involve at least two institutions and commit to engaging at least two patient advisors.
The Foundation to Advance Vascular Cures supports early-stage, innovative research on the relationship between metabolic dysfunction and vascular disease, particularly peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI). Developed through the Vascular Health Innovation Summit, the program funds exploratory, multidisciplinary, translational, and implementation-focused projects that may be difficult to support through traditional funding mechanisms.
Priorities include metabolic pathways, GLP-1 receptor agonists and related therapies, biomarkers, wound healing, precision vascular medicine, and patient engagement. Projects may also address trust, health literacy, adherence, community engagement, clinical trial infrastructure, and implementation of evidence-based therapies. The goal is to generate preliminary data, partnerships, methodologies, and strategic plans that position projects for larger federal, foundation, or industry-supported funding.